EE349 The Impact of Using Real-World Data on the Cost-Effectiveness of Fremanezumab for Migraine Prevention in a UK Healthcare Perspective Analysis
Dec 1, 2023, 00:00 AM
10.1016/j.jval.2023.09.615
https://www.valueinhealthjournal.com/article/S1098-3015(23)03745-2/fulltext
Section Title :
Section Order :
10105
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03745-2&doi=10.1016/j.jval.2023.09.615